Jul. 31 at 2:49 AM
$CDNA The way I view this the reward/risk ration is 3/1. After the collapse of the stock, management put out a statement, cryptic as it was, that they did not believe that there was going to be any hit to them. Further, that they would discuss at 8/6/25 conference call. That says to me the sell off was way over done. Even assuming the worse, downside is
$11.00. There should be good profitability to the quarter, and any good news regarding the news that drove the stock down could easily see this get back to pre-collapse levels (
$19). So we have
$6 upside and only
$2 downside. This was a
$24 stock not that long ago and a
$99.00 stock 4 years ago. We have. niche business that is critical to the health of transplant patients. I don't think these people are the ones you scrimp on. I am very bullish and I have averaged down to a
$13.00 break even. I am very much looking forward to the CC.
